Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Mouse CD8 beta Antibody (53-5.8)

😃Good
Catalog No. T78259

Anti-Mouse CD8 beta Antibody is a rat-derived IgG1 inhibitor that targets the mouse CD8 beta protein.

Anti-Mouse CD8 beta Antibody (53-5.8)

Anti-Mouse CD8 beta Antibody (53-5.8)

😃Good
Catalog No. T78259
Anti-Mouse CD8 beta Antibody is a rat-derived IgG1 inhibitor that targets the mouse CD8 beta protein.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$732-4 weeks2-4 weeks
5 mg$2682-4 weeks2-4 weeks
10 mgPreferential2-4 weeks2-4 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-Mouse CD8 beta Antibody is a rat-derived IgG1 inhibitor that targets the mouse CD8 beta protein.
Clone
53-5.8
Reactivity
Mouse
Application
FACS
Functional assay
Antibody Type
Monoclonal
Endotoxin< 1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetCD8beta
Chemical Properties
Storage & Solubility Information
Storage-20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-Mouse CD8 beta Antibody (53-5.8) | purchase Anti-Mouse CD8 beta Antibody (53-5.8) | Anti-Mouse CD8 beta Antibody (53-5.8) cost | order Anti-Mouse CD8 beta Antibody (53-5.8)